Prudential Financial’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Prudential Financial’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$435K	Buy	+6,800	New	+$353K	﹤0.01%	1965
2025 Q2	–	Sell	-91,230	Closed	-$2.03M	–	2475
2025 Q1	$2.03M	Sell	91,230 -690	-0.8%	-$14.2K	﹤0.01%	1278
2024 Q4	$1.82M	Sell	91,920 -26,800	-23%	-$612K	﹤0.01%	1334
2024 Q3	$2.97M	Sell	118,720 -22,780	-16%	-$555K	﹤0.01%	1248
2024 Q2	$2.64M	Sell	141,500 -14,710	-9%	-$276K	﹤0.01%	1267
2024 Q1	$3.08M	Sell	156,210 -13,800	-8%	-$270K	﹤0.01%	1197
2023 Q4	$2.98M	Sell	170,010 -29,030	-15%	-$477K	﹤0.01%	1195
2023 Q3	$3.46M	Buy	199,040 +46,200	+30%	+$778K	0.01%	1067
2023 Q2	$2.15M	Buy	152,840 +33,300	+28%	+$446K	﹤0.01%	1359
2023 Q1	$1.29M	Buy	119,540 +31,050	+35%	+$409K	﹤0.01%	1604
2022 Q4	$1.33M	Buy	88,490 +53,200	+151%	+$775K	﹤0.01%	1555
2022 Q3	$453K	Buy	+35,290	New	+$402K	﹤0.01%	2113

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Prudential Financial's KNSA Position: Q2 2026 in Review

Prudential Financial opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 6,800 shares worth $435K. The stake represents ﹤0.01% of the portfolio and ranks #1965 among its holdings. This is a return to the name: Prudential Financial previously reported a position in KNSA as recently as Q1 2025.

Prudential Financial first reported a position in KNSA in Q3 2022 and has held it in 12 quarters since. The position peaked at $3.46M in Q3 2023. 267 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Prudential Financial held 6,800 shares of Kiniksa Pharmaceuticals worth $435K as of Q2 2026.
Kiniksa Pharmaceuticals was a new Prudential Financial position in Q2 2026.
Kiniksa Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1965 holding.
Prudential Financial first reported a position in Kiniksa Pharmaceuticals in Q3 2022 and has held it in 12 quarters since.
Prudential Financial's Kiniksa Pharmaceuticals position peaked at $3.46M in Q3 2023.
267 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.